The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Clinical trial NCT06215976 · RECRUITING

Trial details

NCT number: NCT06215976
Sponsor: Cairo University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Muscle-Invasive Bladder Carcinoma

Start date: 2023-06-01
Primary completion: 2024-06-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.